These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 23360320)
1. A platelet-mimetic paradigm for metastasis-targeted nanomedicine platforms. Modery-Pawlowski CL; Master AM; Pan V; Howard GP; Sen Gupta A Biomacromolecules; 2013 Mar; 14(3):910-9. PubMed ID: 23360320 [TBL] [Abstract][Full Text] [Related]
2. Heteromultivalent liposomal nanoconstructs for enhanced targeting and shear-stable binding to active platelets for site-selective vascular drug delivery. Modery CL; Ravikumar M; Wong TL; Dzuricky MJ; Durongkaveroj N; Sen Gupta A Biomaterials; 2011 Dec; 32(35):9504-14. PubMed ID: 21906806 [TBL] [Abstract][Full Text] [Related]
3. PEGylated liposomal doxorubicin targeted to α5β1-expressing MDA-MB-231 breast cancer cells. Shroff K; Kokkoli E Langmuir; 2012 Mar; 28(10):4729-36. PubMed ID: 22268611 [TBL] [Abstract][Full Text] [Related]
4. Anticancer Platelet-Mimicking Nanovehicles. Hu Q; Sun W; Qian C; Wang C; Bomba HN; Gu Z Adv Mater; 2015 Nov; 27(44):7043-50. PubMed ID: 26416431 [TBL] [Abstract][Full Text] [Related]
5. Platelet membrane-based and tumor-associated platelettargeted drug delivery systems for cancer therapy. Zhang Y; Liu G; Wei J; Nie G Front Med; 2018 Dec; 12(6):667-677. PubMed ID: 29619757 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of the interactions between metastatic human breast cancer cells and platelets by β-nitrostyrene derivatives. Wei CK; Chang FR; Hsieh PW; Wu CC Life Sci; 2015 Dec; 143():147-55. PubMed ID: 26546721 [TBL] [Abstract][Full Text] [Related]
7. Bioinspired and Biomimetic Nanomedicines. Chen Z; Wang Z; Gu Z Acc Chem Res; 2019 May; 52(5):1255-1264. PubMed ID: 30977635 [TBL] [Abstract][Full Text] [Related]
8. The efficacy of WGA modified daunorubicin anti-resistant liposomes in treatment of drug-resistant MCF-7 breast cancer. Liu S; Song XL; Wang YH; Wang XM; Xiao Y; Wang X; Cheng L; Li XT J Drug Target; 2017 Jul; 25(6):541-553. PubMed ID: 28277825 [TBL] [Abstract][Full Text] [Related]
9. Ticagrelor inhibits platelet-tumor cell interactions and metastasis in human and murine breast cancer. Gareau AJ; Brien C; Gebremeskel S; Liwski RS; Johnston B; Bezuhly M Clin Exp Metastasis; 2018 Feb; 35(1-2):25-35. PubMed ID: 29322294 [TBL] [Abstract][Full Text] [Related]
10. Platelet microparticle-inspired clot-responsive nanomedicine for targeted fibrinolysis. Pawlowski CL; Li W; Sun M; Ravichandran K; Hickman D; Kos C; Kaur G; Sen Gupta A Biomaterials; 2017 Jun; 128():94-108. PubMed ID: 28314136 [TBL] [Abstract][Full Text] [Related]
11. Mimicking adhesive functionalities of blood platelets using ligand-decorated liposomes. Ravikumar M; Modery CL; Wong TL; Dzuricky M; Sen Gupta A Bioconjug Chem; 2012 Jun; 23(6):1266-75. PubMed ID: 22607514 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of Integrins in Cancer Cells and Anti-Platelet Properties Are Involved in Holothurian Glycosaminoglycan-Mediated Disruption of the Interaction of Cancer Cells and Platelets in Hematogenous Metastasis. Qian W; Tao L; Wang Y; Zhang F; Li M; Huang S; Wang A; Chen W; Yue Z; Chen L; Liu Y; Huang C; Zhang L; Li Y; Lu Y J Vasc Res; 2015; 52(3):197-209. PubMed ID: 26488158 [TBL] [Abstract][Full Text] [Related]
13. Beyond the thrombus: Platelet-inspired nanomedicine approaches in inflammation, immune response, and cancer. Desai C; Koupenova M; Machlus KR; Sen Gupta A J Thromb Haemost; 2022 Jul; 20(7):1523-1534. PubMed ID: 35441793 [TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo hemostatic capabilities of a functionally integrated platelet-mimetic liposomal nanoconstruct. Modery-Pawlowski CL; Tian LL; Ravikumar M; Wong TL; Sen Gupta A Biomaterials; 2013 Apr; 34(12):3031-41. PubMed ID: 23357371 [TBL] [Abstract][Full Text] [Related]
15. A platelet-inspired paradigm for nanomedicine targeted to multiple diseases. Modery-Pawlowski CL; Kuo HH; Baldwin WM; Sen Gupta A Nanomedicine (Lond); 2013 Oct; 8(10):1709-27. PubMed ID: 24074391 [TBL] [Abstract][Full Text] [Related]
16. Cancer-associated-platelet-inspired nanomedicines for cancer therapy. Geranpayehvaghei M; Dabirmanesh B; Khaledi M; Atabakhshi-Kashi M; Gao C; Taleb M; Zhang Y; Khajeh K; Nie G Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Sep; 13(5):e1702. PubMed ID: 33538125 [TBL] [Abstract][Full Text] [Related]
17. A factor VIII-derived peptide enables von Willebrand factor (VWF)-binding of artificial platelet nanoconstructs without interfering with VWF-adhesion of natural platelets. Haji-Valizadeh H; Modery-Pawlowski CL; Sen Gupta A Nanoscale; 2014 May; 6(9):4765-73. PubMed ID: 24658160 [TBL] [Abstract][Full Text] [Related]
18. Engineered breast tumor targeting peptide ligand modified liposomal doxorubicin and the effect of peptide density on anticancer activity. Shahin M; Soudy R; Aliabadi HM; Kneteman N; Kaur K; Lavasanifar A Biomaterials; 2013 May; 34(16):4089-4097. PubMed ID: 23465829 [TBL] [Abstract][Full Text] [Related]
20. The use of a tumor metastasis targeting peptide to deliver doxorubicin-containing liposomes to highly metastatic cancer. Wang Z; Yu Y; Dai W; Lu J; Cui J; Wu H; Yuan L; Zhang H; Wang X; Wang J; Zhang X; Zhang Q Biomaterials; 2012 Nov; 33(33):8451-60. PubMed ID: 22940213 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]